Mirati Therapeutics (MRTX) – Analyst Ratings
-
Citi Downgrades Mirati Therapeutics (MRTX) to Neutral
-
Leerink Partners Downgrades Mirati Therapeutics (MRTX) to Market Perform
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MRTX Stock Lookup